Publications

  • Radhika Radha Maniswami, Seema Prashanth, Archana Venkataramana Karanth, Sindhu Koushik, Hemalatha Govindaraj, Ramesh Mullangi, Sriram Rajagopal & Sooriya Kumar Jegatheesan

     
    PLK4: a link between centriole biogenesis and cancer
     
    Expert Opinion on Therapeutic Targets, 2017
     
    https://doi.org/10.1080/14728222.2018.1410140
  • Swaminathan S, Birudukota S, Thakur MK, Parveen R, Kandan S, Juluri S, Shaik S, Anand NN, Burri RR, Kristam R, Hallur MS, Rajagopal S, Schreuder H, Langer T, Rudolph C, Ruf S, Dhakshinamoorthy S, Gosu

    Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide.

    Biochem Biophys Res Commun. 2017 Sep 16;491(2):416-422

    https://www.ncbi.nlm.nih.gov/pubmed/28720493

  • Sindhu Koushik, Nivedita Joshi, Shruthi Nagaraju, Sameer Mahmood, Krishna Mudeenahally, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi and Sriram Rajagopal

    PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis

    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017

    http://dx.doi.org/10.1080/14728222.2017.1294160

  • Manish Kumar Thakur, Swarnakumari Bridukota, Srinivasan Swaminathan, Sivarama Krishna Battula, Sarvanan Vadivelu, Rajiv Tyagi and Ramchandraiah Gosu

    Biochemical and Biophysical Research Communications 482(4):1289-95(2017)

    Co-crystal structures of PTK6:  with dasatinib at 2.24Å, with novel imidazo [1,2-a] pyrazin-8-amine derivative inhibitor at 1.70Å resolution

    http://dx.doi.org/10.1016/j.bbrc.2016.12.030

  • Archana Venkataramana Karanth, Radhika Radha Maniswami, Seema Prashanth, Hemalatha Govindaraj, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi and Sriram Rajagopal

    Emerging role of SETDB1 as a therapeutic target

    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, VOL. 21, NO. 3, 319–331

    http://dx.doi.org/10.1080/14728222.2017.1279604